Hot Features
Premium
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Período:
Tipo de Línea:
| Volume | 26,906 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 0.4315 | Mínimo Máximo |
|||||
| Minimo del Dia | 0.411 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| NeuBase Therapeutics Inc | NBSE | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| -0.0049 | -1.18% | 0.4111 | 18:59:35 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 0.4273 | 0.411 | 0.4315 | 0.4121 | 0.416 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 101 | 26,906 | US$ 0.4191681 | US$ 11,278 | - | 0.39 - 4.80 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 18:59:35 | 19 | US$ 0.411 | USD |
Información Financiera NeuBase Therapeutics Inc NBSE
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 1.53M | 3.73M | - | 0 | -33.78M | -9.06 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre NeuBase Therapeutics Inc NBSE
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 05/4/2024 | 15:05 | GlobeNewswire Inc. | NeuBase Therapeutics Announces Receipt of Notice from Nasdaq |
| 07/3/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 23/2/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 26/1/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17/1/2024 | 05:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28/12/2023 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28/12/2023 | 05:15 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 22/12/2023 | 05:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 27/11/2023 | 08:00 | GlobeNewswire Inc. | Psychemedics Corporation Appoints Daniella Mehalik as VP -.. |
| 09/11/2023 | 15:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 06/11/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20/10/2023 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos NBSE
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.428 | 0.45 | 0.411 | 0.4363465 | 23,485 | -0.0169 | -3.95% |
| 1 Month | 0.4493 | 0.4653 | 0.39 | 0.419088 | 51,554 | -0.0382 | -8.50% |
| 3 Months | 0.6952 | 1.15 | 0.39 | 0.7550782 | 245,240 | -0.2841 | -40.87% |
| 6 Months | 0.6419 | 1.51 | 0.39 | 0.8580633 | 295,293 | -0.2308 | -35.96% |
| 1 Year | 3.06 | 4.80 | 0.39 | 1.92 | 803,353 | -2.65 | -86.57% |
| 3 Years | 120.80 | 121.60 | 0.39 | 12.94 | 400,221 | -120.39 | -99.66% |
| 5 Years | 90.00 | 257.80 | 0.39 | 49.13 | 331,738 | -89.59 | -99.54% |
